Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tongqiang Li, Qin Shi, Jiacheng Liu, Yingliang Wang, Chen Zhou, Chaoyang Wang, Shuguang Ju, Songjiang Huang, Chongtu Yang, Yang Chen, Yaowei Bai & Bin Xiong. (2021) Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization. Journal of Hepatocellular Carcinoma 8, pages 1525-1535.
Read now
Read now
Liumei Shou, Tianyu Shao, Fangmin Zhao, Shuyi Chen, Qunwei Chen & Qijin Shu. (2021) The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand–Foot Skin Reaction. Cancer Management and Research 13, pages 45-53.
Read now
Read now
Jiangxia Du, Hao Yan, Zhifei Xu, Bo Yang, Qiaojun He, Xiaohong Wang & Peihua Luo. (2021) Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 17:11, pages 1311-1325.
Read now
Read now
Articles from other publishers (20)
Dan YangJiaojiao DuWeijie NieChaozhi WangZhufang Ma. (2023) Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion. Medicine 102:45, pages e35713.
Crossref
Crossref
Liumei Shou, Jialu Chen, Tianyu Shao, Yao Zhang, Shuya Zhao, Shuyi Chen & Qijin Shu. (2023) Clinical characteristics, treatment outcomes, and prognosis in patients with MKIs-associated hand-foot skin reaction: a retrospective study. Supportive Care in Cancer 31:7.
Crossref
Crossref
Yuan Fang, XiaoLi Zhang, HanFei Huang & Zhong Zeng. (2023) The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things. Journal of Translational Medicine 21:1.
Crossref
Crossref
Dylan Haynes, Eric E. Morgan & Emily Y. Chu. (2023) Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings. Human Pathology.
Crossref
Crossref
长丰 苗. (2023) Arnebiae Oil Combined with Epidermal Growth Factor for the Treatment of Sorafenib-Induced Hand-Foot Syndrome in 2 Cases. Advances in Clinical Medicine 13:03, pages 3336-3341.
Crossref
Crossref
Devansi Sarawgi, Madhumita Das, Subhasmita Baisya & Sumit Sen. (2022) Hand-Foot Skin Reaction by Sorafenib. Journal of the Turkish Academy of Dermatology 16:4, pages 104-107.
Crossref
Crossref
Jessa Gilda P. Pandy, Paula Isabel G. Franco & Rubi K. Li. (2022) Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials. Supportive Care in Cancer 30:11, pages 8655-8666.
Crossref
Crossref
Tzu-Chen Lan, Po-Han Tsou, Ka-Wai Tam & Tsai-Wei Huang. (2022) Effect of Urea Cream on Hand-Foot Syndrome in Patients Receiving Chemotherapy. Cancer Nursing 45:5, pages 378-386.
Crossref
Crossref
Satoshi Nishioka, Tomomi Watanabe, Masaki Asano, Tatsunori Yamamoto, Kazuyoshi Kawakami, Shuntaro Yada, Eiji Aramaki, Hiroshi Yajima, Hayato Kizaki & Satoko Hori. (2022) Identification of hand-foot syndrome from cancer patients’ blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms. PLOS ONE 17:5, pages e0267901.
Crossref
Crossref
Wenwen Nie, Yang Lu, Chenghao Pan, Jian Gao, Mengxin Luo, Jiaming Du, Jiao Wang, Peihua Luo, Hong Zhu, Jinxin Che, Qiaojun He & Xiaowu Dong. (2022) Design, synthesis, and biological evaluation of quinazoline derivatives with covalent reversible warheads as potential FGFR4 inhibitors. Bioorganic Chemistry 121, pages 105673.
Crossref
Crossref
Caio Bezerra Machado, Flávia Melo Cunha de Pinho Pessoa, Emerson Lucena da Silva, Laudreísa da Costa Pantoja, Rodrigo Monteiro Ribeiro, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro, Rommel Mário Rodriguez Burbano, André Salim Khayat & Caroline Aquino Moreira-Nunes. (2021) Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations. Pharmaceutics 13:10, pages 1604.
Crossref
Crossref
Jorge L. Rodriguez‐Gil, Simona E. Bianconi, Nicole Farhat, David E. Kleiner, Marie Nelson & Forbes D. Porter. (2021)
Hepatocellular carcinoma as a complication of Niemann‐Pick disease type
C1
. American Journal of Medical Genetics Part A 185:10, pages 3111-3117.
Crossref
Crossref
Jinxin Che, Xiaoyang Dai, Jian Gao, Haichao Sheng, Wenhu Zhan, Yang Lu, Dan Li, Zizheng Gao, Zegao Jin, Binhui Chen, Peihua Luo, Bo Yang, Yongzhou Hu, Qiaojun He, Qinjie Weng & Xiaowu Dong. (2021)
Discovery of
N
-((3
S
,4
S
)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1
H
-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity
. Journal of Medicinal Chemistry 64:16, pages 12163-12180.
Crossref
Crossref
Jiexiu Chen & Zhuo Wang. (2021) How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs. Journal of Oncology Pharmacy Practice 27:4, pages 919-929.
Crossref
Crossref
Hui Xia, Cheng Zhou, Zhaoxia Luo, Ping Zhang, Liping Zhu & Zhao Gong. (2021) Apatinib-Induced Hand–Foot Skin Reaction in Chinese Patients With Liver Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Yi-Siao Chen, Hsun-Shuo Chang, Hui-Hua Hsiao, Yih-Fung Chen, Yi-Ping Kuo, Feng-Lin Yen & Chia-Hung Yen. (2021) Identification of Beilschmiedia tsangii Root Extract as a Liver Cancer Cell–Normal Keratinocyte Dual-Selective NRF2 Regulator. Antioxidants 10:4, pages 544.
Crossref
Crossref
Hexu Han, Ting Lin, Ziyi Fang & Guoxiong Zhou. (2021) RBM23 Drives Hepatocellular Carcinoma by Activating NF-κB Signaling Pathway. BioMed Research International 2021, pages 1-9.
Crossref
Crossref
Valerie M. Carlberg, Olivia M. T. Davies, Heather A. Brandling‐Bennett, Sarah E. S. Leary, Jennifer T. Huang, Carrie C. Coughlin & Deepti Gupta. (2020) Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy. Pediatric Dermatology 38:1, pages 18-30.
Crossref
Crossref
Lei Wang, Huijiao Cao, Chang Jiang, Wenzhuo He, Yafei You, Kunwei Peng, Yanan Jin & Liangping Xia. (2020) Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies. Frontiers in Oncology 10.
Crossref
Crossref
欣 姚. (2020) Sorafenib in the Treatment of Hepatocellular Carcinoma. Advances in Clinical Medicine 10:10, pages 2241-2245.
Crossref
Crossref